Zdrowie i gospodarka · 16/03/2021
FDA Clears Sodium Nitroprusside for Sale After Safety Review
The FDA has determined that NIPRIDE RTU, a sodium nitroprusside solution, was not withdrawn from sale due to safety concerns, paving the way for potential approval of abbreviated new drug applications for this product.